Author

Xiaoqin Zhou

Children's Hospital of Chongqing Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Luyi Wang· 2 shared Ying Zhang· 2 shared Yongjun DangiD· 2 shared Chuanjie Wang· 1 shared Dan Li· 1 shared Jia He· 1 shared Jianmin WuiD· 1 shared Jiaxue Wu· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Luyi Wang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintNov 1, 2026

Homoharringtonine targets XPC to inhibit DNA damage repair and sensitize tumors to platinum-based chemotherapy

Chuanjie Wang, Ying Zhang, Xiaoqin Zhou…·Jiaxue Wu

This paper identifies homoharringtonine as a DDR inhibitor that targets XPC to impair DNA repair and enhance platinum-based chemotherapy efficacy.

DOI 10.64898/2026.10.27.762176

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 30, 2026

p300/CBP-Driven Acetylation Stabilizes PARP7 to Reinforce Negative Feedback on IFN-I Signaling

Dan Li, Yao Liu, Ying Wang…·Jianmin Wu

This study identifies p300/CBP-mediated acetylation of PARP7 as a mechanism to suppress IFN-I signaling in tumor cells, with implications for enhancing antitumor immunity.

DOI 10.64898/2026.01.28.702217

humanproteomics

𝕏 PostBluesky